> top > docs > PMC:7417201 > spans > 9829-15324 > annotations

PMC:7417201 / 9829-15324 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T20 1723-1727 Body_part denotes Body http://purl.org/sig/ont/fma/fma256135
T21 1773-1778 Body_part denotes Chest http://purl.org/sig/ont/fma/fma9576
T22 2547-2562 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T23 3465-3469 Body_part denotes Body http://purl.org/sig/ont/fma/fma256135
T24 3545-3550 Body_part denotes Chest http://purl.org/sig/ont/fma/fma9576
T25 4187-4202 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T26 4975-4979 Body_part denotes Body http://purl.org/sig/ont/fma/fma256135
T27 5030-5035 Body_part denotes Chest http://purl.org/sig/ont/fma/fma9576
T28 5472-5487 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T22 1773-1778 Body_part denotes Chest http://purl.obolibrary.org/obo/UBERON_0001443
T23 2547-2562 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T24 2556-2562 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T25 3545-3550 Body_part denotes Chest http://purl.obolibrary.org/obo/UBERON_0001443
T26 4187-4202 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T27 4196-4202 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T28 5030-5035 Body_part denotes Chest http://purl.obolibrary.org/obo/UBERON_0001443
T29 5472-5487 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T30 5481-5487 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T54 1145-1153 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T55 1314-1322 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 1822-1830 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T57 1968-1980 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T58 2021-2035 Disease denotes Hyperlipidemia http://purl.obolibrary.org/obo/MONDO_0021187
T59 2127-2130 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T61 2543-2546 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T63 2547-2570 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T64 2556-2570 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T65 2673-2681 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T66 2806-2820 Disease denotes hyperlipidemia http://purl.obolibrary.org/obo/MONDO_0021187
T67 2831-2834 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T69 3039-3047 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T70 3064-3076 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T71 3177-3185 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T72 3609-3617 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T73 3796-3808 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T74 3862-3876 Disease denotes Hyperlipidemia http://purl.obolibrary.org/obo/MONDO_0021187
T75 3996-3999 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T77 4183-4186 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T79 4187-4210 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T80 4196-4210 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T81 4268-4280 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T82 4302-4305 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T84 4391-4399 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T85 4584-4592 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T86 4750-4758 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 4849-4851 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T88 4874-4876 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T89 5078-5086 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T90 5220-5232 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T91 5271-5285 Disease denotes Hyperlipidemia http://purl.obolibrary.org/obo/MONDO_0021187
T92 5374-5377 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T94 5415-5417 Disease denotes SE http://purl.obolibrary.org/obo/MONDO_0002125
T95 5468-5471 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T97 5472-5495 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T98 5481-5495 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T79 8-9 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T80 72-77 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T81 214-218 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T82 438-442 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T83 578-580 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T84 666-670 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T85 682-684 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T86 815-820 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T87 852-853 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T88 870-874 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T89 1214-1218 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T90 1387-1391 http://purl.obolibrary.org/obo/CLO_0001185 denotes 2018
T91 1648-1650 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T92 1664-1666 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T93 1672-1676 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T94 1672-1676 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T95 1773-1778 http://www.ebi.ac.uk/efo/EFO_0000965 denotes Chest
T96 1796-1798 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T97 1813-1815 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T98 1998-2001 http://purl.obolibrary.org/obo/CLO_0054060 denotes 102
T99 2147-2149 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T100 2209-2213 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T101 2230-2232 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T102 2242-2244 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T103 2264-2268 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T104 2323-2326 http://purl.obolibrary.org/obo/CLO_0001377 denotes 462
T105 2328-2330 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T106 2336-2338 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T107 2345-2347 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T108 2392-2394 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T109 2400-2403 http://purl.obolibrary.org/obo/CLO_0001195 denotes 219
T110 2405-2407 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T111 2556-2562 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T112 2556-2562 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T113 3331-3338 http://purl.obolibrary.org/obo/CLO_0007929 denotes n = 418
T114 3365-3367 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T115 3385-3387 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T116 3393-3401 http://purl.obolibrary.org/obo/CLO_0001040 denotes 11 < .05
T117 3402-3406 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T118 3402-3406 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T119 3446-3448 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T120 3545-3550 http://www.ebi.ac.uk/efo/EFO_0000965 denotes Chest
T121 3557-3565 http://purl.obolibrary.org/obo/CLO_0007926 denotes n (%) 22
T122 3637-3639 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T123 3690-3692 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T124 3721-3723 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T125 3752-3754 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T126 3756-3758 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T127 3764-3766 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T128 3824-3826 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T129 3954-3956 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T130 3976-3979 http://purl.obolibrary.org/obo/CLO_0054061 denotes 132
T131 4034-4036 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T132 4196-4202 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T133 4196-4202 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T134 4556-4560 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T135 4556-4560 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T136 4926-4930 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T137 4926-4930 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T138 5030-5035 http://www.ebi.ac.uk/efo/EFO_0000965 denotes Chest
T139 5481-5487 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T140 5481-5487 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T18 4556-4560 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T19 4849-4851 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T20 4874-4876 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813
T21 5415-5417 Chemical denotes SE http://purl.obolibrary.org/obo/CHEBI_74813

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T70 0-7 Sentence denotes Results
T71 8-230 Sentence denotes A total of 1361 stress SPECT-MPI were considered, including all tests performed during the pandemic between February and May 2020 and those performed in the corresponding months of the prior 3 years (2017, 2018, and 2019).
T72 231-472 Sentence denotes The number of stress SPECT-MPI studies performed during the pandemic (n = 123) was significantly lower (P < 0.0001) compared with the mean number of procedures in the corresponding months of the years 2017, 2018, and 2019 (n = 413) (Fig. 1).
T73 473-696 Sentence denotes However, the percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65) during the pandemic (36%) compared with mean percentage value of the corresponding months of the years 2017, 2018, and 2019 (34%) (Fig. 2).
T74 697-882 Sentence denotes Of note, given the mean number of 139 abnormal stress SPECT-MPI in the previous 3 years and the number of 44 abnormal tests during the pandemic, there was a 68% of abnormal test missed.
T75 883-1002 Sentence denotes Baseline characteristics of the entire population according to the year of SPECT-MPI execution are reported on Table 1.
T76 1003-1082 Sentence denotes Most of the considered variables were comparable between the two study periods.
T77 1083-1251 Sentence denotes Fig. 1 Number of stress SPECT-MPI procedures performed during COVID-19 pandemic and during corresponding months of the years 2017, 2018, and 2019 (P for trend < 0.0001)
T78 1252-1402 Sentence denotes Fig. 2 Prevalence of abnormal stress SPECT-MPI studies during COVID-19 pandemic and during the corresponding months of the years 2017, 2018, and 2019.
T79 1403-1477 Sentence denotes The percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65)
T80 1478-1571 Sentence denotes Table 1 Baseline characteristics of overall population according to the year of MPI execution
T81 1572-1630 Sentence denotes All (n = 1361) 2020 (n = 123) 2017–2019 (n = 1238) P value
T82 1631-1671 Sentence denotes Age (years) 64 ± 11 64 ± 10 64 ± 11 0.14
T83 1672-1722 Sentence denotes Male gender, n (%) 439 (32) 29 (24) 410 (33) < .05
T84 1723-1772 Sentence denotes Body mass index (kg/m2) 29 ± 5 29 ± 5 29 ± 6 0.43
T85 1773-1821 Sentence denotes Chest pain, n (%) 468 (34) 37 (30) 431 (35) 0.29
T86 1822-1868 Sentence denotes Diabetes, n (%) 437 (32) 47 (38) 390 (32) 0.12
T87 1869-1914 Sentence denotes Dyspnea, n (%) 624 (46) 49 (40) 575 (46) 0.16
T88 1915-1967 Sentence denotes Family history, n (%) 729 (54) 60 (49) 669 (54) 0.26
T89 1968-2020 Sentence denotes Hypertension, n (%) 1070 (79) 102 (83) 968 (78) 0.22
T90 2021-2073 Sentence denotes Hyperlipidemia, n (%) 949 (70) 92 (75) 857 (69) 0.20
T91 2074-2120 Sentence denotes Smoking, n (%) 416 (31) 26 (21) 390 (32) < .05
T92 2121-2168 Sentence denotes Known CAD, n (%) 593 (44) 52 (42) 541 (44) 0.76
T93 2169-2188 Sentence denotes Stress type < .0001
T94 2189-2245 Sentence denotes   Physical exercise test, n (%) 519 (38) 11 (9) 508 (41)
T95 2246-2302 Sentence denotes   Pharmacological test, n (%) 842 (62) 112 (91) 730 (59)
T96 2303-2353 Sentence denotes Abnormal MPI, n (%) 462 (34) 44 (36) 418 (34) 0.65
T97 2354-2413 Sentence denotes Total perfusion defect > 10% 246 (53) 27 (61) 219 (52) 0.26
T98 2414-2508 Sentence denotes Values are expressed as mean value ± standard deviation or as number (percentage) of subjects.
T99 2509-2570 Sentence denotes MPI myocardial perfusion imaging, CAD coronary artery disease
T100 2571-2750 Sentence denotes Characteristics of overall population are also described according to stress SPECT-MPI results during COVID-19 pandemic and during the corresponding months of 2017–2019 (Table 2).
T101 2751-3089 Sentence denotes In both study periods, the percentage of patients with hyperlipidemia and known CAD was higher in patients with abnormal compared with those with normal stress SPECT-MPI findings, while during 2017–2019, patients with abnormal SPECT-MPI were older (P < 0.05) and had higher prevalence of diabetes (P < 0.005) and hypertension (P < 0.001).
T102 3090-3246 Sentence denotes Table 2 Clinical characteristics of overall population according to MPI results during COVID-19 emergency and during 2017–2019 3-year’s corresponding months
T103 3247-3261 Sentence denotes 2020 2017–2019
T104 3262-3347 Sentence denotes Normal (n = 79) Abnormal (n = 44) P value Normal (n = 820) Abnormal (n = 418) P value
T105 3348-3401 Sentence denotes Age (years) 64 ± 11 64 ± 8 0.77 63 ± 11 65 ± 11 < .05
T106 3402-3464 Sentence denotes Male gender, n (%) 23 (38) 6 (43) 0.05 337 (41) 73 (17) < .001
T107 3465-3544 Sentence denotes Body mass index (kg/m2) 28.9 ± 4.9 28.1 ± 4.4 0.38 29.1 ± 6.1 27.9 ± 4.2 < .001
T108 3545-3608 Sentence denotes Chest pain, n (%) 22 (38) 15 (43) 0.47 308 (38) 123 (29) < .005
T109 3609-3670 Sentence denotes Diabetes, n (%) 28 (19) 19 (36) 0.40 234 (29) 156 (37) < .005
T110 3671-3729 Sentence denotes Dyspnea, n (%) 29 (22) 20 (25) 0.34 375 (46) 200 (48) 0.48
T111 3730-3795 Sentence denotes Family history, n (%) 36 (48) 24 (41) 0.34 446 (54) 223 (53) 0.73
T112 3796-3861 Sentence denotes Hypertension, n (%) 66 (62) 36 (76) 0.81 614 (75) 354 (85) < .001
T113 3862-3930 Sentence denotes Hyperlipidemia, n (%) 54 (55) 38 (57) < .05 540 (66) 317 (76) < .001
T114 3931-3989 Sentence denotes Smoking, n (%) 15 (55) 11 (57) 0.43 258 (31) 132 (32) 0.97
T115 3990-4053 Sentence denotes Known CAD n (%) 21 (55) 31 (57) < .001 224 (27) 317 (76) < .001
T116 4054-4148 Sentence denotes Values are expressed as mean value ± standard deviation or as number (percentage) of subjects.
T117 4149-4210 Sentence denotes MPI myocardial perfusion imaging, CAD coronary artery disease
T118 4211-4462 Sentence denotes At multivariable logistic regression analysis (Table 3), hypertension (P < 0.05) and known CAD (P < 0.001) were significantly associated with abnormal stress SPECT-MPI during both COVID-19 pandemic and the corresponding months of the previous 3 years.
T119 4463-4521 Sentence denotes No significant interactions among risk factors were found.
T120 4522-4651 Sentence denotes During the 2017–2019 period, also male gender (P < 0.001) and diabetes (P < 0.05) were associated with abnormal stress SPECT-MPI.
T121 4652-4819 Sentence denotes Table 3 Multivariable logistic regression analysis with abnormal MPI as dependent variable during COVID-19 emergency and during 2017–2019 3-year’s corresponding months
T122 4820-4834 Sentence denotes 2020 2017–2019
T123 4835-4884 Sentence denotes β coefficient SE P value β coefficient SE P value
T124 4885-4925 Sentence denotes Age 0.005 0.023 0.834 − 0.004 0.007 0.60
T125 4926-4974 Sentence denotes Male gender 0.162 0.639 0.799 0.671 0.166 < .001
T126 4975-5029 Sentence denotes Body mass index − 0.013 0.049 0.785 − 0.024 0.014 0.08
T127 5030-5077 Sentence denotes Chest pain 0.542 0.508 0.286 − 0.264 0.149 0.08
T128 5078-5122 Sentence denotes Diabetes 0.565 0.466 0.225 0.310 0.148 < .05
T129 5123-5174 Sentence denotes Family history 0.180 0.454 0.692 − 0.163 0.150 0.28
T130 5175-5219 Sentence denotes Dyspnea 0.362 0.382 0.343 − 0.085 0.120 0.48
T131 5220-5270 Sentence denotes Hypertension − 1.573 0.709 < .05 0.376 0.196 < .05
T132 5271-5322 Sentence denotes Hyperlipidemia 0.822 0.621 0.186 − 0.239 0.167 0.15
T133 5323-5367 Sentence denotes Smoking 0.619 0.533 0.245 − 0.102 0.152 0.50
T134 5368-5414 Sentence denotes Known CAD 0.137 0.541 <.001 1.994 0.154 < .001
T135 5415-5495 Sentence denotes SE standard error, MPI myocardial perfusion imaging, CAD coronary artery disease

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T12 1773-1783 Phenotype denotes Chest pain http://purl.obolibrary.org/obo/HP_0100749
T13 1869-1876 Phenotype denotes Dyspnea http://purl.obolibrary.org/obo/HP_0002094
T14 1968-1980 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T15 2021-2035 Phenotype denotes Hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077
T16 2806-2820 Phenotype denotes hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077
T17 3064-3076 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T18 3545-3555 Phenotype denotes Chest pain http://purl.obolibrary.org/obo/HP_0100749
T19 3671-3678 Phenotype denotes Dyspnea http://purl.obolibrary.org/obo/HP_0002094
T20 3796-3808 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T21 3862-3876 Phenotype denotes Hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077
T22 4268-4280 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T23 5030-5040 Phenotype denotes Chest pain http://purl.obolibrary.org/obo/HP_0100749
T24 5175-5182 Phenotype denotes Dyspnea http://purl.obolibrary.org/obo/HP_0002094
T25 5220-5232 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T26 5271-5285 Phenotype denotes Hyperlipidemia http://purl.obolibrary.org/obo/HP_0003077

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
135 1145-1153 Disease denotes COVID-19 MESH:C000657245
137 1314-1322 Disease denotes COVID-19 MESH:C000657245
146 2127-2165 Gene denotes CAD, n (%) 593 (44) 52 (42) 541 (44) 0 Gene:730249
147 1779-1783 Disease denotes pain MESH:D010146
148 1822-1830 Disease denotes Diabetes MESH:D003920
149 1869-1876 Disease denotes Dyspnea MESH:D004417
150 1968-1980 Disease denotes Hypertension MESH:D006973
151 2021-2035 Disease denotes Hyperlipidemia MESH:D006949
152 2169-2175 Disease denotes Stress MESH:D000079225
153 2303-2315 Disease denotes Abnormal MPI MESH:C535740
161 3551-3555 Disease denotes pain MESH:D010146
162 3609-3617 Disease denotes Diabetes MESH:D003920
163 3671-3678 Disease denotes Dyspnea MESH:D004417
164 3796-3808 Disease denotes Hypertension MESH:D006973
165 3862-3876 Disease denotes Hyperlipidemia MESH:D006949
167 3177-3185 Disease denotes COVID-19 MESH:C000657245
178 2831-2834 Gene denotes CAD Gene:730249
179 2792-2800 Species denotes patients Tax:9606
180 2849-2857 Species denotes patients Tax:9606
181 2955-2963 Species denotes patients Tax:9606
182 2673-2681 Disease denotes COVID-19 MESH:C000657245
183 2806-2820 Disease denotes hyperlipidemia MESH:D006949
184 3039-3047 Disease denotes diabetes MESH:D003920
185 3064-3076 Disease denotes hypertension MESH:D006973
193 5374-5377 Gene denotes CAD Gene:730249
194 4825-4876 Disease denotes 2017–2019 β coefficient SE P value β coefficient SE MESH:C000657245
195 5036-5040 Disease denotes pain MESH:D010146
196 5078-5086 Disease denotes Diabetes MESH:D003920
197 5175-5182 Disease denotes Dyspnea MESH:D004417
198 5220-5232 Disease denotes Hypertension MESH:D006973
199 5271-5285 Disease denotes Hyperlipidemia MESH:D006949
201 4750-4758 Disease denotes COVID-19 MESH:C000657245
204 5415-5417 Disease denotes SE
205 5468-5495 Disease denotes CAD coronary artery disease MESH:D003324
210 4302-4305 Gene denotes CAD Gene:730249
211 4268-4280 Disease denotes hypertension MESH:D006973
212 4391-4399 Disease denotes COVID-19 MESH:C000657245
213 4584-4592 Disease denotes diabetes MESH:D003920

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T65 1145-1153 SP_7 denotes COVID-19
T66 1314-1322 SP_7 denotes COVID-19
T67 2248-2263 CHEBI:52217;CHEBI:52217 denotes Pharmacological
T68 2513-2523 UBERON:0002349 denotes myocardial
T69 2547-2562 UBERON:0001621 denotes coronary artery
T70 2673-2681 SP_7 denotes COVID-19
T50079 1145-1153 SP_7 denotes COVID-19
T44925 1314-1322 SP_7 denotes COVID-19
T52972 2248-2263 CHEBI:52217;CHEBI:52217 denotes Pharmacological
T82716 5438-5448 UBERON:0002349 denotes myocardial
T1355 5472-5487 UBERON:0001621 denotes coronary artery